Accuray and China Isotope form joint venture for radiation oncology systems in China

Accuray Asia Limited and CNNC High Energy Equipment (Tianjin) Co., Ltd., a subsidiary of China Isotope and Radiation Corporation, formed a joint venture named CNNC Accuray (Tianjin) Medical Technology Co., Ltd. to manufacture and sell radiation oncology systems in China. CIRC's subsidiary will own 51% and Accuray's subsidiary 49%.

“Accuray and CIRC believe that the JV...will be uniquely positioned to serve the world's largest growth market for radiation oncology systems.”biopharmawatch.com

• 1 source
• biopharmawatch.comACCURAY AND CHINA ISOTOPE AND RADIATION CORPORATION ENTER JOINTBiopharmaWatch ResearchJan 28, 2019

Summarized from public sources; check the original articles before acting on it.